Neuren Pharma tumbles 14pc on short-seller report
NEW YORK: Neuren Pharmaceuticals has rebuked a short seller report targeting its US-listed drug licensing
NEW YORK: Neuren Pharmaceuticals has rebuked a short seller report targeting its US-listed drug licensing
FEATURED
Operator opens new homes for seniors in regional city
Best affordable seniors housing design for Global Awards shortlisted
Bank to support housing for seniors and people with disability
Multigenerational housing makes comeback as market conditions improve
New research confirms dementia growth in all generations
Boomer turned 1000 straw bales into a fortress-like house
INNOVATION
